The common test for H. pylori ('the stomach germ') is the test with the highest rate of false-positive results.
Original statement
دقيق او شارب بيبسي هتديك فازك برض ها والبس بقى يا معلم الجرثومه الشائيه اهي اعلى تحليل فولس بوزيتيف كفته ما فيش دور برد دور البرد تسمم بطاطس تسمم لحمه اي
verbatim according to source. Translation by the project; the Arabic wording is authoritative.
Translation
The common test for H. pylori ('the stomach germ') is the test with the highest rate of false-positive results.
Origin
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- حقيقه جرثومه المعده . #ضياء_العوضي (Open source)
- Published
- 15 December 2025
- Timestamp
- 0:12:24 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
- Attribution uncertainty
- Transcript is YouTube CC or machine-generated (no timestamps); wording may contain speech-recognition errors. Speaker attribution within live streams/podcasts is not marked in the transcript; the excerpt was judged to be Elawady's own speech from context. Recurrence = number of archive transcripts matching the keyword pattern ['جرثومه|الجرثومه|بيلوري'] (approximate; includes re-uploads/clips; 76 distinct text passages).
- Claimed mechanism
Not stated in this excerpt (other videos: low stomach acid caused by flour, tea, soda and PPIs is the real problem).
- Claimed health effect
Not applicable.
- Population concerned
People tested for H. pylori.
- Geographic restriction by Elawady
none found; he does not limit this statement to a country or to a production system
Diverging source versions
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- Dr Diaa Al Awady د ضياء العوضي is live! الجرثومة (Open source)
- Published
- 8 December 2025
- Timestamp
- not available (transcript has no timings)
- Attribution uncertainty
- Further video in which the same statement recurs; no excerpt recorded. Archive transcript without timestamps.
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- Dr Diaa Al Awady د ضياء العوضي is live!صباح الخير اتباع العوضي (Open source)
- Published
- 19 September 2025
- Timestamp
- not available (transcript has no timings)
- Attribution uncertainty
- Further video in which the same statement recurs; no excerpt recorded. Archive transcript without timestamps.
Scientific assessment
Mostly false – Essential parts of the statement are not supported by the evidence or are strongly exaggerated.
Certainty of evidence: moderate – Further research may still affect the assessment.
1. What was claimed?
The common H. pylori test is the test with the highest false-positive rate (in context: 700 of 1000 positives are false; acid suppressants, low acid, flour or soft drinks give positive results).
2. What is demonstrably correct?
No non-invasive test is perfect, and serology and stool antigen tests are less accurate than urea breath tests (diagnostic odds ratios 47.4 and 45.1 vs 153 for 13C breath test) (I-INTB-14). Antibody (serology) tests cannot distinguish a past from a current infection (general knowledge; not quantified in the abstract). A 2026 diagnostic meta-analysis confirms that antibody tests are less specific when previously infected people are included (specificity 0.861 vs 0.967; I-SRC-120).
3. What is wrong or exaggerated?
'700 of 1000 positives are false' is contradicted: in the Cochrane model scenario with 1000 people tested (specificity 0.90, prevalence 53.7%) there were 46 false positives (I-INTB-14), i.e. most positive results are true. Acid-suppressing drugs and recent antibiotics mainly cause false negative results, which is why studies excluded such patients (I-INTB-14). No evidence was found that eating flour or drinking soft drinks makes the test positive. H. pylori is a recognised infection whose treatment prevents ulcer recurrence and gastric cancer (I-GUT-01, I-GUT-02, I-GUT-03). Even with this lower specificity, 70% of positive results would be false only where fewer than about 6% of people are infected; in Africa about 70% carry H. pylori (I-SRC-121), so most positives are true (our calculation).
4. What remains unclear?
Exact false-positive rates vary by test brand, threshold and local laboratory.
5. Which studies support it?
I-INTB-14, I-SRC-120 (lower accuracy of serology, especially after past infection).
6. Which studies contradict it?
I-INTB-14, I-GUT-01, I-SRC-121.
7. What applies to Germany and Europe?
Breath and stool antigen tests are used in Europe; serology is used less for diagnosis.
8. What is known about Egypt?
Serology is widely used in Egypt (general observation, not sourced); a positive antibody test may reflect past infection, so breath or stool tests are preferred for diagnosing current infection.
9. What practical conclusion is appropriate?
If H. pylori testing is needed, a breath or stool test is more reliable than an antibody test. Tell the doctor about recent PPIs or antibiotics.
Assessment details
- Rationale for certainty of evidence
A Cochrane diagnostic review of 101 studies gives test accuracies far better than he claims (I-INTB-14); it is based partly on indirect comparisons and studies with unclear risk of bias, so certainty is moderate.
- Source quality
Machine transcript of a live stream; wording may contain recognition errors; meaning checked in context. In context he says that of 1000 positive results 700 are false, and that acid suppressants, low stomach acid, flour or Pepsi also give positive results.
- Regional transferability
High; Egypt has high H. pylori prevalence, which increases the share of true positives.
- Individual exceptions
Recent antibiotics or PPIs, and prior gastric surgery, affect test accuracy.
- Regional scope of the claim
- general (biological/medical)
- Last reviewed
- 26 October 2026 provisional
Scientific evidence in detail
Overinterpreted – A real finding exists, but the claim draws more from it than the data allow (e.g. association taken as cause, animal data applied to humans, small effect presented as large).
Research question: Do common H. pylori tests produce mostly false-positive results (in context: 700 of 1000 positives false)?
Research question in detail (PICO)
- Population
- People tested for H. pylori
- Intervention or exposure
- Serology, stool antigen, urea breath test
- Comparison
- Reference standard (biopsy-based)
- Geographic scope
- universal test performance; prevalence-dependent (Egypt/Africa high prevalence)
- Outcomes
- Specificity
- Share of false positives among positive results
Study results as reported by the authors. Our assessment follows below.
What speaks for the claim?
How accurate H. pylori blood and stool tests are
Ichita C et al.. Helicobacter 2026 · PMID 42604577 · DOI 10.1111/hel.70157 Meta-analysisabstract checkednewly added2026 Japanese DTA meta-analysis.
- Actual result
- Serum antibody specificity 0.956 overall but 0.861 in studies including previously infected individuals.
- Methodological quality
- high
- Relevance
- direct: serology positive after past infection
- Limitations
- Japan-specific kits.
What speaks against the claim?
How accurate are H. pylori tests?
Best LM et al.. Cochrane Database Syst Rev 2018 · PMID 29543326 · DOI 10.1002/14651858.CD012080.pub2 Meta-analysisabstract checkedCochrane DTA review (101 studies).
- Actual result
- In 1000 people tested (prevalence 53.7%, specificity 0.90) 46 false positives; breath tests DOR 153.
- Methodological quality
- high
- Relevance
- direct
- Limitations
- Some indirect comparisons.
How common H. pylori is worldwide
Hooi JKY et al.. Gastroenterology 2017 · PMID 28456631 · DOI 10.1053/j.gastro.2017.04.022 Meta-analysisabstract checkednewly addedGlobal prevalence meta-analysis.
- Actual result
- Africa pooled prevalence 70.1%.
- Methodological quality
- moderate
- Relevance
- indirect: high prevalence raises PPV
- Limitations
- No Egypt figure in abstract.
What does the overall evidence say?
Editorial assessment based on the studies above – not itself a study result.
Which position is better supported?
H. pylori tests are imperfect but most positive results are correct; antibody tests can stay positive after past infection.
Why some studies weigh more
Cochrane DTA evidence and recalculated predictive values; the serology-after-past-infection issue is real but small.
Is a causal relationship established? Not applicable Diagnostic accuracy question.
Remaining uncertainty
Performance of locally used Egyptian kits.
Justified conclusion
The 70% false-positive figure is not supported; it would require prevalence below about 6% even with the weakest serology estimate.
Does this depend on the country?
- General biological effects
- Test performance universal.
- Eating habits
- Not applicable.
- Origin of the food
- Not applicable.
- Contaminants
- Not applicable.
- National production conditions
- Not applicable.
- Legal rules
- Not applicable.
- Actual monitoring data
- High prevalence in Africa (70.1%) raises predictive values.
A regional difference that changes the conclusion is not supported by robust data.
Statistical re-check
- Share of false positives by prevalence; prevalence needed for 70% false positives – Serology (sens 0.876, spec 0.861): 12% false at 53.7% prevalence, 6.3% at 70.1%; 70% false only if prevalence <=6.4% recalculated
- False positives in Cochrane scenario – (1-0.90) x 463 = 46.3 per 1000 (matches 46) recalculated
Certainty of the overall evidence (GRADE, simplified)
- Main outcome
- Specificity/false-positive share of non-invasive H. pylori tests
- Starting level
- high (randomised trials)
- Reasons for downgrading
- risk of bias in some diagnostic studies
- Result
- moderate
Simplified assessment by a single reviewer, following the GRADE approach; not a formal GRADE panel. GRADE rates the body of evidence for one outcome, not individual studies.
Clinical guidelines and official statements checked
- ACG: ACG Clinical Guideline: Treatment of Helicobacter pylori Infection (2024) · Original publication
Abstract: H. pylori is a prevalent global infection causing dyspepsia, peptic ulcer and gastric cancer; guideline covers who to test and universal post-treatment test-of-cure (specific test recommendations not read).
Search strategy
Documented literature searches for this review (search strings in the original database syntax).
| Database | Date | Search | Looking for | Hits | Included |
|---|---|---|---|---|---|
| PubMed | 26 October 2026 | ACG Clinical Guideline: Treatment of Helicobacter pylori Infection 2024 | guidelines | 2 | |
| Europe PMC | 26 October 2026 | (Helicobacter pylori) AND (Egypt OR Egyptian) AND (serology OR "stool antigen" OR "urea breath test") AND (sensitivity OR specificity OR accuracy OR "false positive") | supporting evidence | 512 | |
| Europe PMC | 26 October 2026 | (Helicobacter pylori) AND (serology OR antibody) AND ("false positive" OR "positive predictive value") AND (low prevalence OR "past infection") | supporting evidence | 2398 | |
| PubMed | 26 October 2026 | Helicobacter pylori prevalence Egypt systematic review meta-analysis | both directions | 9 | |
| PubMed | 26 October 2026 | Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis Hooi | contradicting evidence | 1 |
Open questions
Validation of Egyptian serology kits.
How deeply was this checked?
4 linked studies: 0 checked in full text (0 of them with a structured risk-of-bias assessment), 4 on the basis of the abstract, 0 bibliographically only. No formal assessment with two independent reviewers and no independent human expert review has taken place yet.
Last scientific review: 26 October 2026
History of the verdict
- 25 October 2026 · Phase 1 · Initial assessment: Mostly false (moderate)
- 26 October 2026 · Phase 4 (systematic evidence review) · Re-examined with extended evidence; verdict unchanged: Mostly false (moderate)
New DTA and prevalence data quantify the kernel (serology after past infection) and confirm the verdict.
New sources: I-SRC-120 I-SRC-121
In plain language
Dr. Elawady said the stomach-germ test gives more false positive results than any other test, claiming that 700 of 1000 positives are wrong. A large Cochrane review found that tests can be wrong, but far less often: in a model of 1000 people tested there were about 46 false positives. Breath tests are the most accurate. Blood antibody tests are less reliable because they can stay positive after an old infection. Acid-blocking drugs make tests falsely negative, not positive.
Studies on this claim
Studies supporting the claim (0)
No studies in this group.
Studies contradicting or limiting the claim (3)
-
How accurate are H. pylori tests?
Best LM et al.. Cochrane Database Syst Rev 2018 · PMID 29543326 · DOI 10.1002/14651858.CD012080.pub2Meta-analysisindependent cross-checkabstract checked★ key studyBreath tests are highly accurate; blood and stool tests somewhat less so; about 46 false positives per 1000 tested in a model scenario.
False positives exist but far below his figure.
Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Compare H. pylori tests
- How was the study done?
Cochrane diagnostic review
- How many people, animals or samples were studied?
101 studies, 11,003 people
- What was actually found?
Breath test most accurate
- How large was the observed effect?
sensitivity 0.94 at specificity 0.90
- What do the results mean in everyday life?
A positive breath test is usually correct; blood tests can mislead more often.
- What are the study's limitations?
Indirect comparisons; abstract only
- What does it say about Elawady's specific claim?
Partly true that tests can be falsely positive; false that most positives are wrong.
- Do the results apply to Germany and Europe?
High
- What can explicitly not be concluded from this study?
Cannot give exact false-positive rates for a particular lab in Egypt.
-
Maastricht VI: H. pylori management
Malfertheiner P et al.. Gut 2022 · PMID 35944925 · DOI 10.1136/gutjnl-2022-327745Guideline / position statementindependent cross-checkabstract checkedH. pylori is an infectious disease; infected people should be treated.
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
H. pylori guidance.
- How was the study done?
Consensus.
- What was actually found?
Treat all infected.
- What do the results mean in everyday life?
Treatment is standard.
- What are the study's limitations?
Consensus; COI.
- What does it say about Elawady's specific claim?
Contradicts C-GUT-06.
- Do the results apply to Germany and Europe?
European.
-
How common H. pylori is worldwide
Hooi JKY et al.. Gastroenterology 2017 · PMID 28456631 · DOI 10.1053/j.gastro.2017.04.022Meta-analysisindependent cross-checkabstract checkedAbout 70% of people in Africa carry H. pylori, so most positive tests there are correct.
High regional prevalence makes most positive results true.
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Estimate global prevalence
- How was the study done?
Meta-analysis
- How many people, animals or samples were studied?
184 studies
- What was actually found?
Highest in Africa
- How large was the observed effect?
70.1% Africa
- What do the results mean in everyday life?
Positive tests are usually right where infection is common
- What are the study's limitations?
Heterogeneous studies
- What does it say about Elawady's specific claim?
Contradicts 70% false positives
- Do the results apply to Germany and Europe?
Moderate
- What can explicitly not be concluded from this study?
Egypt-specific figure
No study in this group is marked as key.
Studies with mixed or unclear results (1)
-
How accurate H. pylori blood and stool tests are
Ichita C et al.. Helicobacter 2026 · PMID 42604577 · DOI 10.1111/hel.70157Meta-analysisindependent cross-checkabstract checkedBlood and stool tests were about 92-97% accurate for current infection; blood tests were less specific in people infected before.
Serology specificity falls to 0.861 when previously infected people are included; still far from 70% false positives.
Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Measure test accuracy
- How was the study done?
Diagnostic meta-analysis
- How many people, animals or samples were studied?
43 studies
- What was actually found?
High accuracy; lower for serology after past infection
- How large was the observed effect?
Serology specificity 0.956 (0.861 with past infection)
- What do the results mean in everyday life?
A positive antibody test can reflect an old infection
- What are the study's limitations?
Japan only
- What does it say about Elawady's specific claim?
Partly fits; does not support 70% false positives
- Do the results apply to Germany and Europe?
Moderate
- What can explicitly not be concluded from this study?
Egyptian kit performance
No study in this group is marked as key.
Regional context
Germany / EU
Breath and stool antigen tests are used in Europe; serology is used less for diagnosis.
Egypt
Serology is widely used in Egypt (general observation, not sourced); a positive antibody test may reflect past infection, so breath or stool tests are preferred for diagnosing current infection.
What applies in my country?
General scientific assessment
Mostly false H. pylori tests are imperfect, but most positive results are correct; his figure of 70% false positives is unsupported.
This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.
References
- Non-invasive diagnostic tests for Helicobacter pylori infection.. Best LM et al.. Cochrane Database Syst Rev 2018 · PMID 29543326 · DOI 10.1002/14651858.CD012080.pub2
- Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report.. Malfertheiner P et al.. Gut 2022 · PMID 35944925 · DOI 10.1136/gutjnl-2022-327745
- Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis.. Hooi JKY et al.. Gastroenterology 2017 · PMID 28456631 · DOI 10.1053/j.gastro.2017.04.022
- Diagnostic Accuracy of Serum Antibody, Urine Antibody, and Stool Antigen Tests for Helicobacter pylori in Japan: A Systematic Review and Meta-Analysis.. Ichita C et al.. Helicobacter 2026 · PMID 42604577 · DOI 10.1111/hel.70157